Novo Nordisk president and directors resign after board rift
The logos of Danish pharmaceutical company Novo Nordisk, maker of the successful diabetes and weight loss treatments Ozempic and Wegovy,…
Novo Nordisk A/S
A key step for Novo Nordisk's GLP-1 pill
Novo Nordisk flags fly in front of its office in Bagsvaerd, outside Copenhagen, Denmark, on July 14, 2025. Little Tom…
Eli Lilly Novo Nordisk shares fall on Trump's comments on LPG-1 price
Actions of Eli Lilly and Nordisk fell on Friday, after President Donald Trump said his administration aims to reduce the…
Amgen and other drugmakers launch DTC programs
Amgen's headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | fake images A version of this article first appeared…
Pfizer's new obesity, Metsera, releases drug data
Thomas Fuller | Soup images | LIGHTROCKET | Getty images A version of this article appeared for the first time…
Trump The threat of the pharmaceutical rate decreases after the Pfizer agreement
The president of the United States, Donald Trump, shakes hand with the Pfizer CEO, Albert Bourla (L), while announcing an…
Roche plans to become the best obesity player as CT-388 enters trial
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty…
Eli Lilly plans $ 6.5 billion of Texas manufacturing plant for obesity pill
A representation of Eli Lilly manufacturing facilities in Houston, Texas. Courtesy: Eli Lilly Eli Lilly On Tuesday, he said he…
Pfizer to buy the medication developer to lose weight Metsera
Thomas Fuller | Soup images | LIGHTROCKET | Getty images Pfizer Monday said he would buy drugs to lose weight…
Novo Nordisk Flags Cagrilintide Promise in Hunt for the next obesity medication
The logos of the Danish drug manufacturer Novo Nordisk, manufacturer of the successful diabetes and the treatments for Ozempic and…